Trisol – Percoutaneous Tricuspid Valve Replacement

  • Category: Medical Devices
  • Investment Status: Incubator
  • Medical Field: Cardio-Vascular
  • Patent Status: National
  • Development Status: POC
  • Medical Center: Beilinson
  • Inventors: Dr. Mordehay Vaturi

TriSol Medical – develops a prosthetic percutaneous Tricuspid valve replacement. The Trisol valve is constructed of nitinol frame with specially designed leaflets. Its unique design provides a comprehensive solution to the unique anatomical and functional challenges which arise when treating Tricuspid Regurgitation by a replacement valve.

There are 1.6 million patients suffering from moderate to severe TR in the US. The price of prosthetic valves, which are currently commercial, is around $20K. As such, the total addressable market for Tricuspid replacement valve in the US alone amounts to tens of billions of dollars.